EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease

Ilaria Laudadio, Claudia Carissimi, Noemi Scafa, Alex Bastianelli, Valerio Fulci, Alessandra Renzini, Giusy Russo, Salvatore Oliva, Roberta Vitali, Francesca Palone, Salvatore Cucchiara, Laura Stronati

Inflammation Research · 2024-08 · 73 (8) · 1359-1370

DOI: 10.1007/s00011-024-01901-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation Research, online erschienen am 06.06.2024. Verfasst von Ilaria Laudadio und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. ilaria.laudadio@uniroma1.it. Hauptthemen laut MEDLINE: Organoids, Fibrosis, Transforming Growth Factor beta1, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Università di Roma, Università degli Studi di Roma La Sapienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Intestinal fibrosis is a common complication of Inflammatory Bowel Disease (IBD), namely Crohn's disease (CD) and ulcerative colitis (UC), but the precise mechanism by which it occurs is incompletely understood hampering the development of effective therapeutic strategies. Here, we aimed at inducing and characterizing an inflammation-mediated fibrosis in patient-derived organoids (PDOs) issued from crypts isolated from colonic mucosal biopsies of IBD pediatric patients and age matched-control subjects (CTRLs).

Methods

Inflammatory-driven fibrosis was induced by exposing CTRL-, CD- and UC-PDOs to the pro-inflammatory cytokine TNF-α for one day, followed by a co-treatment with TNF-α and TGF-β1 for three days. Fibrotic response was proven by analyzing inflammatory and fibrotic markers by RT-qPCR and immunofluorescence. Transcriptomic changes were assessed by RNA-sequencing.

Results

Co-treatment with TNF-α and TGF-β1 caused in CTRL- and IBD-PDOs morphological changes towards a mesenchymal-like phenotype and up-regulation of inflammatory, mesenchymal, and fibrotic markers. Transcriptomic profiling highlighted that in all intestinal PDOs, regardless of the disease, the co-exposure to TNF-α and TGF-β1 regulated EMT genes and specifically increased genes involved in positive regulation of cell migration. Finally, we demonstrated that CD-PDOs display a specific response to fibrosis compared to both CTRL- and UC-PDOs, mainly characterized by upregulation of nuclear factors controlling transcription.

Conclusions

This study demonstrates that intestinal PDOs may develop an inflammatory-derived fibrosis thus representing a promising tool to study fibrogenesis in IBD. Fibrotic PDOs show increased expression of EMT genes. In particular, fibrotic CD-PDOs display a specific gene expression signature compared to UC and CTRL-PDOs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsFibrosisTransforming Growth Factor beta1Tumor Necrosis Factor-alphaHumansInflammatory Bowel DiseasesChildFemaleMaleIntestinal MucosaAdolescentCrohn DiseaseColitis, UlcerativeIntestines

Stichwörter der Autor:innen

FibrosisInflammatory Bowel DiseaseOrganoids

Substanzen

Transforming Growth Factor beta1Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. ilaria.laudadio@uniroma1.it.
  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
  • DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via. A. Scarpa, 16, 00161, Rome, Italy.
  • Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
  • Laboratory of Biomedical Technologies, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via Anguillarese 301, 00123, Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. laura.stronati@uniroma1.it.

Förderung

  • Sapienza Università di Roma
  • Università degli Studi di Roma La Sapienza

Zitieren

APA

Laudadio, I., Carissimi, C., Scafa, N., Bastianelli, A., Fulci, V., Renzini, A., Russo, G., Oliva, S., Vitali, R., Palone, F., Cucchiara, S., & Stronati, L. (2024). Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease. Inflammation Research, 73(8), 1359-1370. https://doi.org/10.1007/s00011-024-01901-9

Vancouver

Laudadio I, Carissimi C, Scafa N, Bastianelli A, Fulci V, Renzini A, et al. Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease. Inflammation Research. 2024;73(8):1359-1370. doi:10.1007/s00011-024-01901-9

BibTeX
@article{Laudadio2024,
  author = {Laudadio, Ilaria and Carissimi, Claudia and Scafa, Noemi and Bastianelli, Alex and Fulci, Valerio and Renzini, Alessandra and Russo, Giusy and Oliva, Salvatore and Vitali, Roberta and Palone, Francesca and Cucchiara, Salvatore and Stronati, Laura},
  title = {Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease},
  journal = {Inflammation Research},
  year = {2024},
  volume = {73},
  number = {8},
  pages = {1359--1370},
  doi = {10.1007/s00011-024-01901-9}
}
Kostenlos starten →